- Home
- NMRA vs TMQ Comparison
NMRA vs TMQ Comparison
Compare NMRA & TMQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMRA
- TMQ
- Stock Information
- Founded
- NMRA 2019
- TMQ 2004
- Country
- NMRA United States
- TMQ Canada
- Employees
- NMRA N/A
- TMQ N/A
- Industry
- NMRA
- TMQ Precious Metals
- Sector
- NMRA
- TMQ Basic Materials
- Exchange
- NMRA Nasdaq
- TMQ Nasdaq
- Market Cap
- NMRA 268.5M
- TMQ 249.6M
- IPO Year
- NMRA 2023
- TMQ N/A
- Fundamental
- Price
- NMRA $1.62
- TMQ $2.11
- Analyst Decision
- NMRA Buy
- TMQ
- Analyst Count
- NMRA 8
- TMQ 0
- Target Price
- NMRA $7.14
- TMQ N/A
- AVG Volume (30 Days)
- NMRA 383.3K
- TMQ 513.9K
- Earning Date
- NMRA 11-11-2025
- TMQ 10-07-2025
- Dividend Yield
- NMRA N/A
- TMQ N/A
- EPS Growth
- NMRA N/A
- TMQ N/A
- EPS
- NMRA N/A
- TMQ N/A
- Revenue
- NMRA N/A
- TMQ N/A
- Revenue This Year
- NMRA N/A
- TMQ N/A
- Revenue Next Year
- NMRA N/A
- TMQ N/A
- P/E Ratio
- NMRA N/A
- TMQ N/A
- Revenue Growth
- NMRA N/A
- TMQ N/A
- 52 Week Low
- NMRA $0.61
- TMQ $0.47
- 52 Week High
- NMRA $17.19
- TMQ $2.16
- Technical
- Relative Strength Index (RSI)
- NMRA 47.71
- TMQ 70.27
- Support Level
- NMRA $1.60
- TMQ $1.78
- Resistance Level
- NMRA $1.70
- TMQ $2.16
- Average True Range (ATR)
- NMRA 0.09
- TMQ 0.13
- MACD
- NMRA -0.01
- TMQ 0.05
- Stochastic Oscillator
- NMRA 8.51
- TMQ 90.83
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.
About TMQ Trilogy Metals Inc.
Trilogy Metals Inc is an exploration stage company engaged in mineral exploration. The company focuses on exploring and developing its mineral resource properties, which include the Upper Kobuk Mineral Projects (UKMP or UKMP Projects), in the Ambler mining district located in Alaska, the United States. Its properties include the Arctic copper-zinc-gold-silver project and other mineralized targets within a volcanogenic massive sulfide belt, and it also has a bornite carbonate-hosted copper project.